Cancer of unknown primary site (Q28261809)

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Diagnostic and therapeutic management of cancer of an unknown primary

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Cancer of unknown primary site: missing primary or missing biology?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Metastatic adenocarcinoma of unknown primary site: abnormalities of cellular DNA content and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Molecular classification of unknown primary cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

MET mutations in cancers of unknown primary origin (CUPs).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Treatment for patients with unknown primary cancer and favorable prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Switching benchmarks in cancer of unknown primary: from autopsy to microarray

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Cancer of unknown primary patients with midline nodal distribution: midway between poor and favourable prognosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Cervical lymph node metastases of squamous cell carcinoma from an unknown primary

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Metastatic inguinal nodes from an unknown primary neoplasm. A review of 56 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Neuroendocrine carcinoma of unknown primary site

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Neuroendocrine carcinoma of unknown primary: a systematic review of the literature and a comparative study with other neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Brain metastasis of unknown primary: a diagnostic and therapeutic dilemma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Prognostic factors in unknown primary cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Forty years experience of treating cancer of unknown primary

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Pathologic evaluation of unknown primary cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Breast MR imaging in patients with axillary node metastases and unknown primary malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Carcinoma of unknown primary in the head and neck: comparison between positron emission tomography (PET) and PET/CT

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary tumour: prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Overview of patient management and future directions in unknown primary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Treatment for patients with unknown primary carcinoma and unfavorable prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021

Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961178-1

7 January 2021